Approval · Notice of Compliance 1340 · 2000
NITRONG SR: Notice of Compliance 1340
Issued November 1, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1340
- Date
- November 1, 2000
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Anti-anginal agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NITRONG SR | 01927809 | Cancelled Post Market |
Medicinal ingredients
- NITROGLYCERIN 2.6 MG per TAB